TWM
MRKR icon

Tradition Wealth Management’s Marker Therapeutics MRKR Stock Holding History

Tradition Wealth Management’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-252
Closed -$4K – 1206
2021
Q3 		$4K Hold
252
– – ﹤0.01% 1085
2021
Q2 		$7K Buy
+252
New +$6.63K ﹤0.01% 1015
2021
Q1 		– Sell
-252
Closed -$4K – 937
2020
Q4 		$4K Buy
+252
New +$3.91K ﹤0.01% 873

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Tradition Wealth Management's MRKR Position: Q4 2021 in Review

Tradition Wealth Management sold out of Marker Therapeutics (MRKR) in Q4 2021, closing a stake of 252 shares — an estimated $4K sold.

Tradition Wealth Management first reported a position in MRKR in Q4 2020 and held it in 3 quarters. The position peaked at $7K in Q2 2021. 64 funds tracked by Wall St. Rank hold MRKR as of Q4 2021.

  • Tradition Wealth Management reported no remaining Marker Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Tradition Wealth Management sold 252 Marker Therapeutics shares in Q4 2021, an estimated $4K.
  • Tradition Wealth Management first reported a position in Marker Therapeutics in Q4 2020 and held it in 3 quarters.
  • Tradition Wealth Management's Marker Therapeutics position peaked at $7K in Q2 2021.
  • 64 funds tracked by Wall St. Rank held Marker Therapeutics as of Q4 2021.

Based on Tradition Wealth Management's 13F filing for Q4 2021, filed 14 Feb 2022.